Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5322 ARTÍCULOS , VIENDO DEL 1636 AL 1650

Semi-synthetic CoA-α-Synuclein Constructs Trap N-terminal Acetyltransferase NatB for Binding Mechanism Studies

Pan B, Gardner S, Schultz K, Perez RM, Deng S, Shimogawa M, Sato K, Rhoades E, Marmorstein R, Petersson EJ.

bioRxiv [Preprint]. 2023 Apr 3:2023.04.03.535351. doi: 10.1101/2023.04.03.535351.

Hyperphosphorylated tau Inflicts Intracellular Stress Responses That Are Mitigated by Apomorphine

Song Z, Wang KW, Hagar HC, Chen HR, Kuan CY, Zhang K, Kuo MH.

bioRxiv [Preprint]. 2023 May 17:2023.05.13.540661. doi: 10.1101/2023.05.13.540661.

Sex- and age-specific prevalence and risk factors of depressive symptoms in Parkinson's disease

Niu L, Yao C, Zhang C, Zhou C, Fu Y, Li Y, Yang H, Sun X, Yang J, Zhao P, Yi S, Wang T, Li S, Li J.

J Neural Transm (Vienna). 2023 Oct;130(10):1291-1302. doi: 10.1007/s00702-023-02658-x. Epub 2023 Jul 7.

Shoulder Dysfunction in Parkinson Disease: Review of Clinical, Imaging Findings and Contributing Factors

Paggou D, Stefanis L, Chronopoulos E, Ghika A, Kyrozis A, Balanika A, Baltas C, Potagas C.

J Musculoskelet Neuronal Interact. 2023 Jun 1;23(2):263-280.

Mercury and Parkinson's Disease: Promising Leads, but Research Is Needed

Torrey EF, Simmons W.

Parkinsons Dis. 2023 Sep 16;2023:4709322. doi: 10.1155/2023/4709322. eCollection 2023.

Opicapone versus entacapone: Head-to-head retrospective data-based comparison of healthcare resource utilization in people with Parkinson's disease new to catechol-O-methyltransferase (COMT) inhibitor treatment

Harrison-Jones G, Marston XL, Morgante F, Chaudhuri KR, Castilla-Fernández G, Di Foggia V.

Eur J Neurol. 2023 Oct;30(10):3132-3141. doi: 10.1111/ene.15990. Epub 2023 Aug 19.

Brain DNA methylomic analysis of frontotemporal lobar degeneration reveals OTUD4 in shared dysregulated signatures across pathological subtypes

Fodder K, Murthy M, Rizzu P, Toomey CE, Hasan R, Humphrey J, Raj T, Lunnon K, Mill J, Heutink P, Lashley T, Bettencourt C.

Acta Neuropathol. 2023 Jul;146(1):77-95. doi: 10.1007/s00401-023-02583-z. Epub 2023 May 7.

Revisiting Alpha-Synuclein Pathways to Inflammation

Lyra P, Machado V, Rota S, Chaudhuri KR, Botelho J, Mendes JJ.

Int J Mol Sci. 2023 Apr 12;24(8):7137. doi: 10.3390/ijms24087137.

The systemic immune response in Parkinson's disease: focus on the peripheral immune component

Lauritsen J, Romero-Ramos M.

Trends Neurosci. 2023 Oct;46(10):863-878. doi: 10.1016/j.tins.2023.07.005. Epub 2023 Aug 17.

Alpha-synuclein null mutation exacerbates the phenotype of a model of Menkes disease in female mice

Casey M, Zou D, Pera RAR, Cabin DE.

bioRxiv [Preprint]. 2023 Nov 17:2023.11.15.567255. doi: 10.1101/2023.11.15.567255.

Supportive care of neurodegenerative patients

Armitage AE, Fonkem E.

Front Oncol. 2023 Feb 14;13:1029938. doi: 10.3389/fonc.2023.1029938. eCollection 2023.

Relationship Between Gut Bacteria and Levodopa Metabolism

Xu K, Sheng S, Zhang F.

Curr Neuropharmacol. 2023;21(7):1536-1547. doi: 10.2174/1570159X21666221019115716.

Riddles in the dark: Decoding the relationship between neuromelanin and neurodegeneration in locus coeruleus neurons

Iannitelli AF, Weinshenker D.

Neurosci Biobehav Rev. 2023 Sep;152:105287. doi: 10.1016/j.neubiorev.2023.105287. Epub 2023 Jun 15.

Different pieces of the same puzzle: a multifaceted perspective on the complex biological basis of Parkinson's disease

Müller-Nedebock AC, Dekker MCJ, Farrer MJ, Hattori N, Lim SY, Mellick GD, Rektorová I, Salama M, Schuh AFS, Stoessl AJ, Sue CM, Tan AH, Vidal RL, Klein C, Bardien S.

NPJ Parkinsons Dis. 2023 Jul 13;9(1):110. doi: 10.1038/s41531-023-00535-8.

A systematic review of the applications of markerless motion capture (MMC) technology for clinical measurement in rehabilitation

Lam WWT, Tang YM, Fong KNK.

J Neuroeng Rehabil. 2023 May 2;20(1):57. doi: 10.1186/s12984-023-01186-9.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias